4.6 Article

Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort

Journal

MOVEMENT DISORDERS
Volume 36, Issue 10, Pages 2378-2386

Publisher

WILEY
DOI: 10.1002/mds.28683

Keywords

FMR1 premutation; fragile X-associated tremor; ataxia syndrome; FXTAS Rating Scale

Funding

  1. Waisman Center Core Grant [U54 HD090256]
  2. Marshfield Clinic Research Institute
  3. [R01 HD082110]

Ask authors/readers for more resources

This study compared unselected carriers of premutation (n = 35, 55-101 CGG repeats) with matched controls (n = 61, 29-39 CGG repeats) for FXTAS-type signs. Results showed a statistically significant age-associated elevation in FXTAS-type signs in premutation carriers compared to controls among individuals without potentially confounding comorbid diagnoses.
Background Premutation-sized (55-200) CGG repeat expansions in the FMR1 gene cause fragile X-associated tremor/ataxia syndrome (FXTAS). Most studies of premutation carriers utilized reverse ascertainment to identify patients, leading to a selection bias for larger repeats. As shorter CGG premutation repeats are common in the population, understanding their impact on health outcomes has a potentially large public health footprint. Objective The study's objective was to compare an unselected group of premutation carriers (n = 35, 55-101 CGG repeats) with matched controls (n = 61, 29-39 CGG repeats) with respect to FXTAS-type signs using structured neurological assessments. Methods Three neurologists independently rated signs, using an adapted version of the FXTAS Rating Scale (Leehey MA, Berry-Kravis E, Goetz CG, et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008). This was a double-blind study, as genetic status (premutation vs. control) was known neither by the participants nor by any of the neurologists. Analyses controlled potentially confounding comorbid conditions in the electronic health record (eg, osteoarthritis and stroke) and probed the association of age with signs. Results Although there was no overall difference between carriers and controls, among individuals without any potentially confounding comorbid diagnoses, there was a statistically significant age-associated elevation in FXTAS-type signs in premutation carriers compared to controls. Conclusions Among those who do not have other comorbid diagnoses, women who have CGG repeats at the lower end of the premutation range may be at greater risk for ataxia and parkinsonism than their age peers, although their overall risk of developing such clinical features is low. This study should provide reassurance to those who share characteristics with the present cohort. (c) 2021 International Parkinson and Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available